A stellar first quarter has underscored ResMed’s share price bounce-back from last year’s obesity drug panic, and perhaps put to bed the initial fear of GLP-1s
Michael Gable of Fairmont Equities suggests it’s but a matter of time before ANZ Bank shares break through resistance
Brambles posted weaker than expected first quarter sales, but a number of impacting factors leave analysts confident FY25 guidance will be met as conditions improve
Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements
Nick Scali’s gross margins have been impacted by materially higher than expected freight rates, but such headwinds should not feature permanently
Edited extract from Virgin Millionaire: The step-by-step guide to your first million and beyond by Ben Nash
Earlier today, Tony Sycamore, Market Analyst IG updated his technical views on the Nasdaq, ASX200 and gold
What are the impacts of potential reforms to the payments system in Australia and what about merchant acquirers?
Beach Energy posted strong first quarter numbers and is headed to a production and cash flow inflection in FY26. But broker recommendations are polarised
Michael Gable of Fairmont Equities suggests an opportunity in Perseus Mining shares
